<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03479996</url>
  </required_header>
  <id_info>
    <org_study_id>BRZ 0005-18 CTIL</org_study_id>
    <nct_id>NCT03479996</nct_id>
  </id_info>
  <brief_title>Evaluation of Postoperative Pain After Tension-free Obturator Tape Operation (TVT-O) With or Without Local Anesthetic</brief_title>
  <official_title>Evaluation of Postoperative Pain After Tension-free Obturator Tape Operation (TVT-O) With or Without Local Anesthetic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barzilai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barzilai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      BACKGROUND:

      Compare the pain intensity after TVT-O procedure in the inner part of the thigh where the
      anesthetic substance will be injected versus the inner part of of the thigh without
      anesthetic injection in the same woman.

      The advantage of this work is that this method of testing neutralizes the effect of pain
      thresholds of different women.

      If an advantage will be found in injecting anesthetic as a reduction in postoperative pain,
      it could be recommended for all women who undergo surgery of this kind.

      METHODS:

      Preoperative women will be offered the opportunity to participate in the study after a
      detailed explanation of the study and determine a date for an elective TVT-O procedure. After
      signing the Informed Consent Form, they will undergo a TVT-O procedure with injection of
      anesthetic into one of the obturators membranes. In a random order, Marcaine 5-ml will be
      injected into a left or right obturator membrane.

      One side with Marcaine (Bupivacaine HCL) 0.5% 5 mg / mL Injection,opposite side without
      injection of any anesthetic.

      Before and after surgery, patients will receive Visual Analogue Scale (VAS) instruction and
      will be polled at the following time points: 1,6,12,24 hours after surgery per inner part of
      the thigh separately. Each patient will rate the intensity of the pain she feels on the pain
      questionnaire at each of the time points mentioned before.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 13, 2018</start_date>
  <completion_date type="Actual">June 22, 2020</completion_date>
  <primary_completion_date type="Actual">June 22, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Leg pain</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>VAS score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leg pain</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>VAS score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leg pain</measure>
    <time_frame>12 hours after surgery</time_frame>
    <description>VAS score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leg pain</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>VAS score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Anesthetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Marcaine 0.5 % Injectable Solution</intervention_name>
    <description>Intra -operative injection into obturator membrane</description>
    <arm_group_label>Anesthetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Women undergoing TVT-O

        Exclusion Criteria:

        • Repeat surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ofer Gemer, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barzilai Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barzilay University Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG. 2007 May;114(5):522-31. Epub 2007 Mar 16. Review. Erratum in: BJOG. 2007 Oct;114(10):1311.</citation>
    <PMID>17362484</PMID>
  </reference>
  <reference>
    <citation>Cheng D, Liu C. Tension-free vaginal tape-obturator in the treatment of stress urinary incontinence: a prospective study with five-year follow-up. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):228-31. doi: 10.1016/j.ejogrb.2012.01.011. Epub 2012 Feb 13.</citation>
    <PMID>22336228</PMID>
  </reference>
  <reference>
    <citation>Duckett J, Baranowski A. Pain after suburethral sling insertion for urinary stress incontinence. Int Urogynecol J. 2013 Feb;24(2):195-201. doi: 10.1007/s00192-012-1863-3. Epub 2012 Jul 3. Review.</citation>
    <PMID>22752013</PMID>
  </reference>
  <reference>
    <citation>Hazewinkel MH, Hinoul P, Roovers JP. Persistent groin pain following a trans-obturator sling procedure for stress urinary incontinence: a diagnostic and therapeutic challenge. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Mar;20(3):363-5. doi: 10.1007/s00192-008-0714-8. Epub 2008 Sep 4.</citation>
    <PMID>18769847</PMID>
  </reference>
  <reference>
    <citation>Tommaselli GA, Di Carlo C, Formisano C, Fabozzi A, Nappi C. Effect of local infiltration analgesia on post-operative pain following TVT-O: a double-blind, placebo-controlled randomized study. Arch Gynecol Obstet. 2014 Aug;290(2):283-9. doi: 10.1007/s00404-014-3186-8. Epub 2014 Mar 6.</citation>
    <PMID>24599566</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2018</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Barzilai Medical Center</investigator_affiliation>
    <investigator_full_name>ofer gemer</investigator_full_name>
    <investigator_title>Director of gynecological surgery, BMC</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

